Storia in 2 fonti

Evonik invests US$100 million to upgrade its U.S. drug substance contract manufacturing site

ESSEN, Germany, July 8, 2026 /PRNewswire/ -- Evonik is making a significant investment to strengthen manufacturing capabilities at its Lafayette (Tippecanoe), Indiana facility. Over the next five years, the company will invest US$100 million to modernize key equipment –

Raccontata da

adnkronos.com

fiercepharma.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

adnkronos.comStai leggendo1 mese fa

Evonik invests US$100 million to upgrade its U.S. drug substance contract manufacturing site

originale

fiercepharma.com1 mese fa

Evonik plugs $100M into Indiana drug substance plant as US CDMO demand mounts

After pledging earlier this year to bolster its drug substance capabilities in Central Europe, German chemical company Evonik is turning its attention to the U.S. | After pledging earlier this year to bolster its drug…

Evonik invests US$100 million to upgrade its U.S. drug substance contract manufacturing site

Evonik plugs $100M into Indiana drug substance plant as US CDMO demand mounts

Timeline cronologica

Evonik invests US$100 million to upgrade its U.S. drug substance contract manufacturing site

Evonik plugs $100M into Indiana drug substance plant as US CDMO demand mounts